Moreover, LAG-3 contributes to an immunosuppressive environment via inducing IL-6 secretion and impairing IFN-α production in tumor-associated pDCs, and promotes monocytes to release CCL2, resulting in the recruitment of MDSCs [202]. This evidence concerns the gene LAG3 and neoplasm.